This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Hybrid Event
20-22 May, 2025Steigenberger Wiltcher's, Brussels
Hybrid Event
20-22 May, 2025,
Steigenberger Wiltcher's, Brussels

Join Van Bael & Bellis at EU Pharmaceutical Law Forum 2024

You're Invited to EU Pharma Law with an Exclusive 10% Off

We are excited to announce that Van Bael & Bellis will be participating at the EU Pharmaceutical Law Forum on 21-23 May 2024 at the Steigenberger Wiltcher's Hotel, Brussels. And, we are pleased to let you know that as a valued client of Van Bael & Bellis , we have an exclusive 10% discount* for you. Your VIP discount code is: P24VANBAELBELLIS

*T&C's Apply

DUAL DIALOGUE Pricing Developments: Discriminatory Pricing, Discounts and Rebates

  • EC’s consultation on the formal guidelines on the application of Article 102 TFEU to exclusionary abuses of dominance: potential implication to the pharmaceutical industry with respect to discounts and rebates

  • Practical advice on pricing/rebate decisions and negotiations in current economic environment and enforcement landscape

  • How can you resist clawbacks (VPAS) and other austerity measures without falling fowl of competition law compliance?

DUAL DIALOGUE Risks of Compounding and Hospital Exemptions for Approved Products

  • Analysis of business risks posed by Leadiant Case

  • Rise in the use of the “compassionate use” mechanism

  • Examining compounding and the Hospital Exemption 

  • Legal challenges and the wider implications for industry